Pamukcu Rifat 4
4 · Aprea Therapeutics, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Pamukcu Rifat
Director
Transactions
- Award
Common Stock
2022-07-28+5,995→ 7,862 total - Award
Stock Option (right to Buy)
2022-07-28+29,575→ 29,575 totalExercise: $1.09Exp: 2032-07-28→ Common Stock (29,575 underlying)
Holdings
- 10,299(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F3]The Reporting Person serves as Managing Partner of ZNZ Holdings L.L.C..